SBEV vs RNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 07, 2026
SBEV
RNA
Investment Advisor Scores
RNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SBEV | RNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -93.8% | -21.9% | RNA |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.1/100 | 40.7/100 | RNA |
| Profit Margin | 0.0% | -184.1% | SBEV |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SBEV
MarkupPrice above SMA50, rising 50-day trend (37.2% over 20 days), RSI 67
RNA
MarkupPrice above SMA50, rising 50-day trend (2.9% over 20 days), RSI 62
Fundamentals Snapshot
| Metric | SBEV | RNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | -1.8 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.9% | -0.2% |
| Gross Margin | -56.0% | -0.6% |
| Operating Margin | -238.9% | -7.5% |
| EPS | -42.54 | -5.44 |
| Dividend Yield | — | — |